Tetrahydro-pyrrolizinone compounds as LFA-I mediators

Details for Australian Patent Application No. 2006299017 (hide)

Owner Novartis AG

Inventors Baumann, Karl

Agent Davies Collison Cave

Pub. Number AU-B-2006299017

PCT Pub. Number WO2007/039286

Priority 0520376.5 06.10.05 GB; 0520379.9 06.10.05 GB; 0520377.3 06.10.05 GB

Filing date 4 October 2006

Wipo publication date 12 April 2007

Acceptance publication date 4 November 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039286 Priority application(s): WO2007/039286

4 November 2010 Application Accepted

  Published as AU-B-2006299017

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299018-Process for the synthesis of HMG-CoA reductase inhibitors

2006299016-Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2